Torun N, Sherif Z, Garweg J, Pleyer U
Augenklinik, Charité, Universitätsmedizin Berlin, Campus Virchow Klinikum, Augustenburger Platz 1, 13353, Berlin, Deutschland.
Ophthalmologe. 2008 Nov;105(11):1023-8. doi: 10.1007/s00347-008-1694-2.
BACKGROUND/PURPOSE: Ocular toxoplasmosis is the most frequent cause of posterior uveitis in Germany. The purpose of this survey was to evaluate current strategies in the management of ocular toxoplasmosis by uveitis specialists in Germany.
An itemized questionnaire including clinical case reports with authentic photographs was distributed to physician members (n=40) of the German Uveitis Society. In addition, members were categorized regarding their clinical background, professional affiliation and experience with ocular toxoplasmosis.
The completed questionnaire was returned by 72% (29/40) of the members. According to the answers, the majority (70%) of responders base their diagnosis of ocular toxoplasmosis on clinical examination and serological findings. Although a positive IgM titre or increasing IgG titres support the diagnosis only in cases of recently acquired disease, these are reported to support the diagnosis by 58 and 41%, respectively. Invasive procedures such as aqueous humour analysis are performed by 59% of colleagues to establish the diagnosis in selected patients. A total of six antimicrobial agents were reported for treatment in different regimens for typical clinical conditions in patients with recurrent toxoplasmic retinochoroiditis. The combination of pyrimethamine and sulfadiazine is the most commonly used (48%), followed by clindamycin (38%).
Our survey indicates the lack of a "gold standard" for diagnosis and medical treatment in ocular toxoplasmosis. Further efforts have to be undertaken towards a better distribution of available information and to determine strategies for providing standards of continuously updated diagnostic and therapeutic recommendations for routine clinical practice.
背景/目的:在德国,眼部弓形虫病是后葡萄膜炎最常见的病因。本次调查旨在评估德国葡萄膜炎专家对眼部弓形虫病的当前管理策略。
向德国葡萄膜炎学会的医师会员(n = 40)发放了一份包含附有真实照片的临床病例报告的分项问卷。此外,还根据会员的临床背景、专业隶属关系和眼部弓形虫病经验进行了分类。
72%(29/40)的会员返回了填写完整的问卷。根据答案,大多数(70%)应答者基于临床检查和血清学结果诊断眼部弓形虫病。尽管IgM滴度阳性或IgG滴度升高仅在近期感染病例中支持诊断,但据报告分别有58%和41%的应答者认为这些结果支持诊断。59%的同行会进行诸如房水分析等侵入性检查,以对选定患者进行诊断。共有六种抗菌药物被报告用于复发性弓形虫性视网膜脉络膜炎患者典型临床情况的不同治疗方案。乙胺嘧啶和磺胺嘧啶联合用药是最常用的(48%),其次是克林霉素(38%)。
我们的调查表明,眼部弓形虫病在诊断和药物治疗方面缺乏“金标准”。必须进一步努力更好地传播现有信息,并确定为常规临床实践提供持续更新的诊断和治疗建议标准的策略。